A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma

BACKGROUND: To determine the safety, preliminary efficacy, pharmacokinetics, and immunogenicity of a single cycle of RM-1929 photoimmunotherapy, an anti-EGFR antibody cetuximab conjugated with a light-activatable dye (IRDye(®)700DX), in Japanese patients with recurrent head and neck squamous cell ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahara, Makoto, Okano, Susumu, Enokida, Tomohiro, Ueda, Yuri, Fujisawa, Takao, Shinozaki, Takeshi, Tomioka, Toshifumi, Okano, Wataru, Biel, Merrill A., Ishida, Kosuke, Hayashi, Ryuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449763/
https://www.ncbi.nlm.nih.gov/pubmed/34165660
http://dx.doi.org/10.1007/s10147-021-01960-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449763/
https://www.ncbi.nlm.nih.gov/pubmed/34165660
http://dx.doi.org/10.1007/s10147-021-01960-6

Ejemplares similares